Abbvie Submits New Drug Application To US FDA For Tavapadon For Treatment Of Parkinson's Disease

TradingKey - BigBear.ai (BBAI) provided a modest first-quarter update on May 5, and BBAI shares have declined about 26% year to date. The company finalized the acquisition of Ask Sage in January, marking its shift away from a services-heavy government contractor to a platform-centric AI company. The

TradingKey - On Tuesday (May 12), the Bank of Japan released the minutes of its April monetary policy meeting. The minutes revealed that several policy board members believed the central bank may need to raise interest rates soon, with some even suggesting that action could be taken as early as the June meeting.

TradingKey - On May 12, Japanese chip stocks strengthened significantly, with Renesas Electronics rising 7.14%, Sumitomo Metal Mining gaining 5.61%, and SoftBank Group advancing 4.25%. The Nikkei 225 Index climbed more than 700 points at one point during the day.

Tradingkey - The imminent meeting between the U.S. and Chinese heads of state and the upcoming release of U.S. CPI data have fueled a strong "wait-and-see" sentiment in the market. Asia-Pacific stock markets showed mixed performance; Japanese and Taiwanese stocks edged higher, while the rally in South Korean equities paused, closing down 2.29%. The Nikkei 225 Index closed up 0.52% at 62,742.57 points. During the session, it reached a high of 63,218.51 and a low of 52,158.43, continuing to hover at elevated levels.

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.